These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Al-Jamal WT; Kostarelos K Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415 [TBL] [Abstract][Full Text] [Related]
23. Supramolecular Nanomachines as Stimuli-Responsive Gatekeepers on Mesoporous Silica Nanoparticles for Antibiotic and Cancer Drug Delivery. Cheng CA; Deng T; Lin FC; Cai Y; Zink JI Theranostics; 2019; 9(11):3341-3364. PubMed ID: 31244957 [TBL] [Abstract][Full Text] [Related]
24. Nanoparticle-based theranostic agents. Xie J; Lee S; Chen X Adv Drug Deliv Rev; 2010 Aug; 62(11):1064-79. PubMed ID: 20691229 [TBL] [Abstract][Full Text] [Related]
25. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics. Nguyen KT; Zhao Y Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application. Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794 [TBL] [Abstract][Full Text] [Related]
27. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics. Zhang W; Liu M; Liu A; Zhai G Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244 [TBL] [Abstract][Full Text] [Related]
28. Exogenous/Endogenous-Triggered Mesoporous Silica Cancer Nanomedicine. Yang B; Chen Y; Shi J Adv Healthc Mater; 2018 Oct; 7(20):e1800268. PubMed ID: 29938917 [TBL] [Abstract][Full Text] [Related]
30. Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery. Chen W; Glackin CA; Horwitz MA; Zink JI Acc Chem Res; 2019 Jun; 52(6):1531-1542. PubMed ID: 31082188 [TBL] [Abstract][Full Text] [Related]
31. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery. Baeza A; Colilla M; Vallet-Regí M Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898 [TBL] [Abstract][Full Text] [Related]
32. Voltage/pH-Driven Mechanized Silica Nanoparticles for the Multimodal Controlled Release of Drugs. Wang T; Sun G; Wang M; Zhou B; Fu J ACS Appl Mater Interfaces; 2015 Sep; 7(38):21295-304. PubMed ID: 26345470 [TBL] [Abstract][Full Text] [Related]
33. Theranostic nanoparticles engineered for clinic and pharmaceutics. Ma X; Zhao Y; Liang XJ Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606 [TBL] [Abstract][Full Text] [Related]
34. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133 [TBL] [Abstract][Full Text] [Related]
35. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles. Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086 [TBL] [Abstract][Full Text] [Related]
36. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators. Yang Y; Zhang M; Song H; Yu C Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182 [TBL] [Abstract][Full Text] [Related]
37. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents. Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791 [TBL] [Abstract][Full Text] [Related]
38. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835 [TBL] [Abstract][Full Text] [Related]
39. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery. Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579 [TBL] [Abstract][Full Text] [Related]
40. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications. Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]